You have no items in your shopping cart.
Product Details
| Alternate Name | S1 Protein, Spike glycoprotein subunit1, S glycoprotein subunit1, SARS-CoV-2 S1 Protein |
|---|---|
| Gene ID | 43740568 |
| Accession # | P0DTC2 |
| Source | HEK 293 cells |
| Appearance | Lyophilized protein |
| Physical Form Description | Lyophilized powder |
| Molecular Weight | ~120 kDa (8xHis tag at the C-terminus) |
| Purity by SDS-PAGE | > 95% |
| Formulation | Lyophilized from 0.22 µm filtered PBS (pH 7.4) with 5% trehalose |
| Reconstitution Instructions | Centrifuge the vial prior to opening. Reconstitute in sterile PBS (pH 7.4). Do not vortex. |
| Handling | Centrifuge the vial prior to opening. |
| Storage Conditions | -20ºC |
| Shipping Conditions | Gel Pack |
| USAGE | For Research Use Only! Not For Use in Humans. |
Details
SARS-CoV-2, the causative virus of COVID-19, uses the viral Spike (S) protein for host cell attachment and entry. The virus uses multiple host targets including the human protease Furin, Angiotensin converting enzyme 2 (ACE2), Neuropilin-1 (NRP1) and the transmembrane protease serine 2 (TMPRSS2) for host cell entry. The S protein has two domains S1 and S2, where S1 facilitates initial binding to the receptor and the S2 domain drives the membrane fusion and eventual entry of the virus. The S glycoprotein serves as an important target for monoclonal antibodies, entry inhibitors, and vaccines. Within the S1 protein, the conserved receptor-binding domain (RBD) binds with a high affinity for ACE2. Recently, fast-spreading variants were identified in UK, South Africa, and Brazil. In November 2020, the CAL.20C or B.1.429 strain was identified throughout California, which contained the L452R mutation, a substitution from a leucine (L) to arginine (R) in the RBD. Due to this change, the California strain is reported to be roughly 20% more contagious. Additionally, the CDC reports a significant impact on neutralization by some, but not all, therapeutics and a moderate reduction in neutralization using convalescent and post-vaccination sera.
Why buy BioVision Products?
 |
 |
 |
 |
Innovation |
Affordability |
Global Presence |
Technical Support |
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways. |
BioVision is committed to providing the highest quality products at a competitive price. |
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery. |
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently. |
